2 applications named ALASOD PLUS
| Application | Class | Applicant | Filed | Advertised | Opposition |
|---|---|---|---|---|---|
| 6634862ALASOD PLUS | 5Pharmaceuticals and health | East West Pharma India Private Limited | 21 September 2024 | No. 22777 September 2026 | openuntil 7 January 2027 |
| 6634864ALASOD PLUS | 35Advertising, business and retail | East West Pharma India Private Limited | 21 September 2024 | No. 22777 September 2026 | openuntil 7 January 2027 |
Goods and services claimed
Class 5: Pharmaceuticals and health · application 6634862
Pharmaceuticals, medical and veterinary preparations, dietetic food and substances adapted for medical or veterinary use, dietary supplements for human beings and animals
Proposed to be used · Chennai office · full journal entry
Class 35: Advertising, business and retail · application 6634864
Wholesale and retail of Pharmaceuticals and medical preparations, nutraceutical preparations for humans, dietary supplements, advertising, promotional and marketing services for the said goods.
Proposed to be used · Chennai office · full journal entry
Can I use or register "ALASOD PLUS"?
For the same or related goods, probably not. In class 5 (pharmaceuticals and health) and class 35 (advertising, business and retail), a new application for an identical or confusingly similar name is likely to be objected to by the Registry under Section 11 of the Trade Marks Act, 1999, or opposed by the earlier applicant. Closely related classes, such as class 3 (cosmetics and cleaning), class 10 (medical devices), class 30 (staples, spices and confectionery) and class 44 (medical, beauty and agricultural services), carry the same risk.
For unrelated goods, often yes. The same word can be registered by different owners in different classes when the goods are unrelated and the earlier mark is not well known. "ALASOD PLUS" appears in 2 classes; the other 43 may still be open, subject to a search.
A small change rarely helps. Adding a word, changing a letter or using a logo does not avoid conflict on its own: marks are compared as a whole, by look, sound and idea. We already see 2 similar names in the same classes (below).
Similar names in the journal
- ENATVIT ALA PLUSsimilar spelling · class 5 (Pharmaceuticals and health) · Omnimakin Healthcare LLP
- ALASOD B12similar spelling · class 5 (Pharmaceuticals and health) · East West Pharma India Private Limited
Matched by spelling and containment across every issue since August 2021. Our free report and Brand Watch also check sounds-alike names.
Questions about ALASOD PLUS
Is ALASOD PLUS a registered trademark?
ALASOD PLUS has been applied for and advertised in the Trade Marks Journal (2 applications, latest on 7 September 2026). Advertisement means the Registry accepted the application; it is registered only if no opposition succeeds within four months of the journal date. The journal does not record the later outcome, so check the live register before relying on it.
Who applied for the ALASOD PLUS trademark?
As advertised: East West Pharma India Private Limited.
Can I register a trademark similar to ALASOD PLUS?
Not for the same or related goods in class 5, class 35: a confusingly similar name is likely to be refused or opposed. For unrelated goods it may be possible after a search. Ask for a free availability report before you file.
What does "advertised" mean? Read trademark status meanings, how long registration takes and how to run a trademark search.
Source and limits. Built from the Trade Marks Journal published by the Registrar of Trade Marks (a public record), issues from August 2021 onwards, as advertised and subject to transcription errors. The journal shows that an application was accepted and advertised; it does not show what happened afterwards (registration, opposition, withdrawal or abandonment), applications not yet advertised, or marks advertised before August 2021, so this is not the live register status. Applicants may ask for a correction or removal by writing to mehak@trademarkindia.pro. Information only, not legal advice and not a solicitation.